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Summary The European Childhood Leukaemia- Lymphoma Incidence Study (ECLIS) is designed to address
concerns about a possible increase in the risk of cancer in Europe following the nuclear accident in Chernobyl
in 1986. This paper reports results of surveillance of childhood leukaemia in cancer registry populations from
1980 up to the end of 1991. There was a slight increase in the incidence of childhood leukaemia in Europe
during this period, but the overall geographical pattern of change bears no relation to estimated exposure to
radiation resulting from the accident. We conclude that at this stage of follow-up any changes in incidence
consequent upon the Chernobyl accident remain undetectable against the usual background rates. Our results
are consistent with current estimates of the leukaemogenic risk of radiation exposure, which, outside the
immediate vicinity of the accident, was small.
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The accident at the Chernobyl nuclear power plant in the
Ukraine on 26 April 1986 resulted in the dissemination of
radioactive isotopes (principally "lI and 137Cs) across a wide
area of Europe. The concern that this generated, particularly
regarding the risk of cancers induced by excess radiation
exposure, led to the establishment of the European Child-
hood Leukaemia-Lymphoma Incidence Study (ECLIS) to
monitor trends in these diseases in relation to the estimated
exposure levels. The rationale for choosing childhood
leukaemia for this monitoring exercise has been described
elsewhere (Parkin, 1990; Doll et al., 1990). Briefly, leukaemia
shows the earliest and largest relative increase in risk
following radiation exposure, and the risk from exposure in
childhood is greater than at older ages (Shimizu et al., 1990;
Preston et al., 1994). In addition, the availability and quality
of data for childhood cancers tend to be greater than for
cancers in adults.
A previous paper describes the background and methods
of the study (Parkin et al., 1993); here we present the results
of follow-up to the end of 1991, more than 5 years after
exposure began.
Materials and methods
Cancer data
Thirty-six cancer registries in 23 countries are collaborating
in ECLIS by supplying an annual listing of cases of
leukaemia and lymphoma occurring in children aged less
than 15 years. For each case included in the present analysis,
the data comprised six variables: date of diagnosis, date of
birth, sex, place of residence, basis of diagnosis and diagnosis
code [ICD-0 (1st edn) for most registries]. In this paper, we
confine analysis to cases of leukaemia, for which a total of
23 756 cases were reported by the collaborating centres in the
period 1980 -91.
Population at risk
Person - years at risk by sex and single year of age were
calculated for the regions covered by the participating
registries, based on annual mid-year estimates of the
populations obtained by participants from national bureaux
of censuses and statistics. A total of 655 million person-
years of observation have now been accumulated from 1980
to 1991 (61% before and 39% after the accident).
Radiation exposure assessment
The source of data on radiation exposure due to the accident
was the United Nations Scientific Committee on the Effects
of Atomic Radiation (UNSCEAR), as described previously
(Parkin et al., 1993). The data were supplied as the estimated
doses during the first year, years 0-4, and years 0-70
following the accident in different regions of Europe (the
term 'dose' is used to mean individual committed effective
equivalent dose resulting from exposure in a given time
period). The geographical units for which these estimates
were produced were either whole countries or, where the
distribution of exposures within a given country was uneven,
for two to four subregions within the country. Figure 1 shows
the countries and subregions for which the dose estimates
were available.
Table I lists the 35 regions for which data have been
contributed for the study (see below), and the corresponding
dose estimates supplied by UNSCEAR. For some of the
regions listed in Table I only part of the population is
covered by cancer registries, for example France (region 3),
Italy (region 1), Switzerland (regions 2, 3 and 4), Romania
and the former Soviet Union (regions 3 and 4).
The UNSCEAR estimates of exposure were used to obtain
estimates of the average leukaemogenic dose received by
children in the study regions according to the following
assumptions:
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Figure 1 Europe, showing the countries and geographical regions for which environmental exposure estimates are available from
UNSCEAR (1988) (within a country the numbers refer to the regions and do not imply any ranking). The shaded areas represent
those from which cancer data were available in the current analysis.
(1) The leukaemogenic effect of environmental radiation
exposure has a latency of 1 year (this means that, for
example, it is assumed that only the dose received in
utero has an effect in the first year after birth);
(2) The effective dose to the fetus is the same as that to a
free-living individual (as most of the radiation from the
accident is received internally, from '34Cs and '37Cs
ingested with contaminated food);
(3) The total leukaemogenic dose is cumulative, starting
with exposure at conception.
The estimated cumulative doses at the end of the first,
fourth and seventieth years after the accident are shown in
Table I. Figure 2 illustrates the method used to establish dose
estimates for the person-years at risk. The estimated
cumulative dose of an individual aged a at date t was
calculated by integrating the dose over time from conception
until t-l, where 1 is the assumed latency. For this purpose, the
dose was assumed to fall linearly throughout the first year
following the accident and exponentially thereafter. Finally,
these cumulative doses were averaged over calendar years and
single years of age in order to establish compatibility within
the leukaemia incidence data.
The estimated cumulative dose due to the accident is
therefore a function of region and year. It is zero for all
person-years of observation before 1987 (the dose in 1986 is
zero because of the assumed latency of the dose effect of 1
year). From 1987 there is considerable heterogeneity, with 91
million person-years of observation at a cumulative dose of
less than 0.06 mSv and 58 million person-years at more than
0.3 mSv.
Statistical analysis
The possible relationship between leukaemia incidence and
radiation exposure from the accident was studied by
Poisson regression analysis using the computer program
GLIM4 (Francis et al., 1993). The variables studied were
age (in single years 0-14), sex, calendar year (1980-91),
region (n = 34), and dose. The analytical strategy was: (a)
fit a 'null' model that allows for the effects of age, sex,
calendar year, and region, but excludes any effect of
radiation dose, (b) compare the observed distribution of
leukaemia cases by radiation dose, with 'expected' values
calculated using the null model, and (c) calculate formalChildhood leukacmia after Chernobyl
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Table I Effective dose equivalents (mSv) due to the Chernobyl accident by region
Region I year 4 years 70 years
Austria 0.67 1.10 2.86
Belarus 1.96 2.68 5.62
Bulgaria 0.76 0.90 1.51
Czech Republic, region 1 0.28 0.32 0.50
Czech Republic, region 2 0.36 0.45 0.85
Czech Republic, region 3 0.34 0.39 0.60
Denmark 0.03 0.05 0.15
Estonia, Latvia, Lithuania 0.14 0.19 0.40
Finland 0.46 0.73 1.85
Francea 0.15 0.21 0.45
Germany, region 1 0.29 0.37 0.83
Germany, region 2 0.34 0.54 1.36
Germany, region 3 0.18 0.29 0.75
Germany, region 4 0.07 0.10 0.26
Germany, region 5 0.13 0.20 0.51
Germany, region 6 0.49 0.78 2.00
Hungary, region 1 0.28 0.37 0.73
Hungary, region 2 0.18 0.20 0.32
Italya 0.37 0.49 0.94
Netherlands 0.06 0.09 0.23
Norway 0.23 0.33 0.74
Poland 0.27 0.37 0.76
Romaniaa 0.53 0.69 1.38
Russiaa 0.45 0.63 1.39
Slovakia 0.34 0.39 0.60
Slovenia 0.62 1.05 2.79
Sweden, region 1 0.39 0.96 3.32
Sweden, region 2 0.09 0.10 0.16
Sweden, region 3 0.10 0.15 0.32
Switzerlanda, region 2 0.31 0.38 0.64
Switzerlanda, region 3 0.21 0.24 0.40
Switzerlanda, region 4 0.12 0.14 0.24
United Kingdoma, region 1 0.01 0.01 0.02
United Kingdoma, region 2 0.11 0.14 0.27
United Kingdoma, region 3 0.19 0.25 0.48
aRegional rather than national cancer registration data available. Source: UNSCEAR, (1988).
likelihood ratio tests by adding to the model. Three
different models were considered for the null hypothesis.
The first, conventially written as
Model 1: Age*Sex*Year+Region
allows the age-incidence curve to vary in shape between the
sexes and between years, but assumes that the ratio of rates
between regions remains constant. As preliminary analysis
indicated that the age-incidence curves may differ between
the former socialist economies (FSEs) and the remaining
regions, our second model allowed for this:
Model 2: Age*Sex*Year+Region +Age*FSE
Our final null model attempted to fit the data as closely as
possible while still allowing estimation of the dose effect:
Model 3: Age*Sex*Year +Age*Sex*Region
This last model involves the fewest assumptions, but its
use is computationally intensive. None of the models used
included the interaction term Region*Year, as this is
confounded with cumulative radiation dose. Tests for trend
within specific age groups (0, 1-4, 5-9 and 10-14) and birth
cohorts (- 1980, 1981-86, 1987 and 1988-) were obtained
by fitting Age Group*Dose and Cohort*Dose interaction
terms. The same categories of age and birth cohort were used
in the presentation of results.
Results
The radiation exposure to the populations of all the regions
studied due to Chernobyl was small, with the highest level at
about 2 mSv in year 1 in Belarus (Table I). This is slightly
lower than the natural background annual dose (around
2.4 mSv).
The model fitting results are summarised in Table II. At
first sight, none of the three base models seems to provide
an adequate fit to the data when assessed by their deviance
statistics. However, the degree of over-dispersion is modest
and the presence of many sparse cells in the data (fewer
than half the cells in the input table contained more than
one case) raises doubts about the usual assumption of a chi-
squared distribution for the overall deviance (McCullagh
and Nelder, 1989). It should be noted that this does not
invalidate tests based on comparisons of deviance statistics
of nested models. Model 2 is a significantly better fit than
model 1 (x2= 142.0 on 14 d.f., P<0.0001), which confirms
that the age-incidence relationship was different in regions
in the former socialist economies in comparison with other
regions. This is illustrated in Figure 3, which plots age-
incidence curves for the two main regional groupings before
the accident (1980-86). Model 3 provides only a modest
improvement in fit compared with model 2, at considerable
cost in terms of parsimony. However, this model involves
the fewest assumptions about the null distribution of
leukaemia and provides the safest test of the exposure effect.
When using model 1 to represent the null hypothesis, there
was no suggestion of an overall relationship between
leukaemia risk and radiation exposure, but there was some
suspicion of an Age*Dose interaction. The parameter
estimates for dose were larger for the two younger compared
with the two older age groups, but this was statistically
significant only for age group 1 -4 in model 1. However,
these apparent effects were diminished when the trend tests
were applied to model 2, indicating that dose is confounded
with differences in the age distributions between western
European and FSE countries. When model 3 was used as theChildhood leukaemia after Chernobyl
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Figure 3 Age distributions of childhood leukaemia in former
socialist economies (-O-) and other European countries (-A-).
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Figure 2 Illustration of the method of calculation of dose. The
box in the upper graph contains all points (t,a) representing
subjects aged 2 at any time in 1989. The method of estimating the
effective dose at (t,a) consists of integrating the dose rate curve
shown in the lower graph from conception to time t-1. In order
to obtain dose estimates conforming to the population estimates
and registry incidence data (available in units of single years of
age and calendar time), an average dose within each age/calendar
year category was calculated.
base model, in which differences in the age distributions
between regions were unrestricted, there was no indication of
an age-specific effect of dose.
In all study regions combined, there was an increase in the
overall age-standardised rate of childhood leukaemia in the
period 1980-86 (average annual change +0.6%). There is no
indication of an increase in the gradient of this trend after the
Chernobyl accident in 1987-91 (average annual change
+0.4%). Neither is there any evidence of change in trends
in age-specific rates before and after the accident, as shown in
Figure 4.
Table III shows observed and expected cases by
cumulative radiation dose. Since zero dose is completely
confounded with year, the observed and expected cases are
identical in the zero dose line of the table. The remaining cells
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Figure 4 Trends in age-specific incidence rates of childhood
leukaemia in all ECLIS study regions in 1980-91. Age: 0, - - -;
1-4, ----;59 10-14;
provide an opportunity for testing the dose effect but there
was no suggestion, either of heterogeneity between the dose
categories (X' =0.98, 3 d.f. or of a trend with dose when fitted
as a continuous variable (X'=0.85, 1 d.f.).
We considered whether or not use of the most complex
model 3 involved a loss of statistical power to detect an
exposure effect. Table II shows that, as expected, the
standard error of the dose effect increases with the
complexity of the base models, but to a negligible extent.
The standard error of the dose parameter estimate of model 3
was used to assess the power of the study to detect effects of
the magnitude observed in other exposed populations. These
power estimates, based on one-sided tests at the 5% level of
statistical significance, are reported in the Discussion.
Table IV shows the observed and expected cases tabulated
Table II Model deviance statistics, and parameter estimates and standard errors (s.e.) for dose effect (expressed as the
excess relative risk (ERR)/mSv)
Model Deviance df. ERR/mSv s.e.
1. Age*Sex*Year+ Region 13340.22 11667
+ Dose 13340.18 11666 -0.0056 0.031
(change) 0.04 1
2. Age*Sex*Year+ Region +Age*FSE 13198.20 11653
+ Dose 13197.44 11652 -0.0267 0.031
(change) 0.76 1
3. Age*Sex*Year+Age*Sex*Region 12020.27 10710
+Dose 12019.42 10709 -0.0222 0.032
(change) 0.85 1
Ag:2 in
0
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_
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Table HI Observed and expecteda number of cases of childhood
leukaemia and observed/expected ratios by dose category
Cumulative
excess Observed Expected
dose (mSv) cases cases Ratio
0 15004 15004.0 -
0.01-0.05 3870 3862.2 1.002
0.06-0.12 2172 2151.7 1.009
0.13-0.29 2022 2037.7 0.992
0.30+ 2752 2764.5 0.995
aBased on model 3.
by dose category and age. There is no suggestion of
heterogeneity of effect across the dose categories (x2= 16.4,
9 d.f.) and none of the individual tests for trend approaches
significance.
Table V shows the observed and expected numbers of
cases for all regions combined, further tabulated by
(approximate) birth cohort. Of particular interest is the
1987 cohort, which contains children who received the largest
exposures in utero. The trend in risk with dose for this cohort
was not statistically significant (x2=0.72, 1 d.f.).
Discussion
Based upon the estimates of excess relative risk of leukaemia
in children exposed to radiation from the atomic bombs in
Hiroshima and Nagasaki, we estimated that the number of
cases of childhood leukaemia expected as a result of the first-
year exposures to radiation from Chernobyl would be too
small to distinguish from the background incidence rate
(Parkin, 1990). The only possible exception was in Belarus,
where the average first-year excess effective dose equivalent
(2 mSv) was about the same as the normal background
radiation level, which could increase incidence by about 6%,
if the BEIR V estimates apply (Parkin, 1990). After 5 years of
follow-up the power of the study to detect an excess of this
magnitude (approximately 25 cases) is still less than 80%.
We observed a small increase in leukaemia incidence over
time in Europe as a whole, but there did not appear to be any
association between the overall risk of leukaemia in the
period 1987-91 and the estimated doses received (after
allowance for the effects of age, sex, time and region of
residence). Again, however, it should be noted that, at this
stage of follow-up, the study has low power to detect a trend
in risk with dose. If the excess risk per unit dose estimated
from the atomic bomb survivors (Doll et al., 1990) is applied
to the childhood population at risk following the Chernobyl
accident, then the power of the study is about 50%. This may
overstate the statistical power, since the protracted low-dose
exposures due to the accident differ in quality, and probably
also in leukaemogenic effect, from the acute high-dose
exposures associated with the atomic bombings.
Although the effect of in utero exposure to radiation
remains controversial, some studies, particularly the Oxford
Survey of Childhood Cancers, have found a markedly higher
risk associated with irradiation during the first trimester of
pregnancy (UNSCEAR, 1994). However, we found no
suggestion of an increase in risk of childhood leukaemia for
children exposed in utero, even among the 1987 birth cohort
in Belarus, some of whom would have received in utero
exposures in excess of 1 mSv.
We estimated the leukaemogenic dose of radiation by
assuming a 1 year latency between exposure and effect, and
that the effect of radiation exposure would be cumulative.
This assumption is based on the observation that leukaemia
risk increases quite rapidly after exposure to external
radiation (Darby et al., 1987); increasing the latency period
to 2 years before estimating dose has the effect of producing
smaller cumulative dose estimates but had no effect on results.
It is recognised that adjustments could have been made to the
estimates of the effective dose to average individuals (adults)
in order to provide more appropriate dose values for
consideration of leukaemia incidence in children, for example
Table IV Observed (and expecteda) numbers of cases of leukaemia, by age group, in relation to estimated cumulative excess dose
Cumulative Age (years)
excess <1 1-4 5-9 10-14
dose (mSv) Obs (Exp) Obs (Exp) Obs (Exp) Obs (Exp)
0 775 (775.0) 6796 (6796.0) 4364 (4364.0) 3069 (3069.1)
0.01-0.05 513 (506.3) 2054 (2048.8) 767 (772.2) 536 (534.8)
0.06-0.12 43 (53.7) 1063 (1084.3) 644 (608.5) 422 (405.2)
0.13-0.29 6 (7.6) 977 (952.7) 652 (655.0) 387 (422.4)
0.30 13 (7.3) 982 (990.2) 1043 (1070.3) 714 (696.7)
x2 trend 0.26 0.12 0.72 0.28
(1 d.f.)
aBased on model 3. Obs, observed; exp, expected.
Table V Observed and expected numbers of cases of leukaemia, by birth cohort, in relation to estimated cumulative excess dose
Cumulative Birth cohort:
excess -1980 1981-86 1987 1988-
dose (mSv) Obs (Exp) Obs (Exp) Obs (Exp) Obs (Exp)
0 12083 (12083.1) 2921 (2921.0) 0 (0.0) 0 (0.0)
0.01-0.05 852 (872.7) 1381 (1340.4) 319 (327.7) 1318 (1321.4)
0.06-0.12 691 (651.1) 925 (938.5) 225 (237.1) 331 (325.0)
0.13-0.29 617 (647.1) 1006 (997.5) 269 (260.8) 130 (132.4)
0.30+ 937 (926.2) 1426 (1461.7) 290 (277.4) 99 (99.3)
x2 trend 0.02 0.36 0.72 0.24
(1 d.f.)
Obs, observed; exp, expected.-lukoda ab CFw
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by using food consumption amounts for children and by
considering more specifically the equivalent dose to the bone
marrow. For the latter parameter, the internal dose from '"'I
contributes somewhat to the effective dose but much less to
the equivalent dose to the bone marrow. For most such
considerations, the dose estimates would be reduced only
slightly. It has also been noted that dose estimates based on
environmental transfer of radionucides, as assumed here,
have overesimated the effective dose when comparisons could
be made with whole-body measurements. The dose estimates
are thus only broadly indicative ofactual doses that may have
been received in specific areas and are probably somewhat
overestimated.
The study has been analysed as a cohort study, with the
allocation of dose to individuals as a function of place of
residence and time since the accident. The actual exposure of
individuals within the populations studied is unknown, of
course, and imputed values from the population averages
were used. Migration between study regions would give rise
to exposure misclassification and attenuation of the estimated
effect. However, it is ikely that inter-regional migration of
children in the 5 years of post-accident observation time has
been small and will contribute only to a small extent to
incorrect exposure estimation.
We chose to use the UNSCEAR estimates of average
effective dose equivalents for quite large areas, since these
were available for the whole of Europe. Certain national
bodies have produced their own estimates, based on different
sets of assumptions and models but generally offering more
geographical precision, and these have been used in two
recent studies. Thus, ground levels of radiation from '37Cs in
Sweden measured in May-October 1986 were used to divide
the childhood population into 'unexposed' (<10 kBq m-)
and 'exposed' (>lO kBq m-) groups in order to compare
leukaemia incidence before and after the Chernobyl accident
(Hjalmars et al., 1994). The population weighted mean of
environmental '37Cs contamination in the exposed region
(29 Bq m-2) (which corresponds almost exactly to region 1 of
Sweden in Figure 1) is the same as the UNSCEAR (1988)
estimate (31 Bq m-2) used as the basis of dose calculation in
the present report. Six and a half years after the accident, 50
cases of leukaemia would be expected in the 'exposed'
population in which individuals would have received a
cumulative dose of around 1 mSv (Table I), giving an
expected excess relative risk (ERR) of 3-5%, or 1-3
additional cases. It is clear that this Swedish study had no
prospect ofdetecting a statistically significant excess incidence
of childhood leukaemia unless the generally accepted
assumptions about radiation leukaemogenesis are incorrect
by a factor of 5-10. In a study using more appropriate
epidemiological methods conducted in Finland (Auvinen et
al., 1994), the average population dose (0.41 mSv over 2
years), derived from atmospheric sampling and whole-body
counts, was partitioned in quintiles. The 95% confidence
interval of the ERR estimate was -0.27 to +0.41. This
range includes a leukaemogenic effect that is almost ten times
greater than is conventionally assumed (0.045). The authors
ofthese two studies imply that more accurate dose estimation
confers an advantage over ECLIS. It seems obvious that any
such advantage is heavily outweighed by lack of power to
detect an effect. Ivanov et al. (1993) have compared incidence
rates of childhood leukaemia in Belarus before (1979-85)
and after (1986-91) the Chernobyl accident for regions with
'severe', 'intermediate' and 'least' radioactive contamination.
No differences in incidence were reported. These results are
difficult to evaluate, since no quantitative information on
exposure is given.
A possible source of bias in this study is differential
ascertainment of cases correlated with exposure; for example,
as a result of improved detection of cases in heavily exposed
populations living near Chernobyl. It is a potential problem
for cancers that can exist in a 'latent' form and be diagnosed
as a consequence of an active search for them. Ascertainment
bias was suggested as a possible cause of the reported excess
of thyroid cancer in children in Belarus (Beral and Reeves,
1992; Ron et al., 1992), although this now seems an unlikely
explanation (Williams et al., 1993). There is no evidence of
ascertainment bias in data for childhood leukaemia in
Europe. Data submitted to ECLIS are checked for the
traditional indicators of data quality used by cancer
registries, including the proportion of leukaemia cases of
unspecified cell type and the proportion with a histological
diagnosis (Parkin et al., 1993). Although most registries do
show small improvements in the latter indicator, there was, in
fact, no association between the observed change (1987-91
vs 1980-85) and the estimated radiation dose.
The study will continue data collection for a period of 10
years post accident, so that the full potential of the excess
radiation exposure can be studied. Future studies will
examine in more detail the trends in incidence within
different age groups and geographical regions, estimate the
possible effects of migration and study separately urban and
rural populations.
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